Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
INTERMOLECULAR INC (IMI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/30/2019 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 09/24/2019 |
4
| MARTIN WILLIAM C (10% Owner) has filed a Form 4 on INTERMOLECULAR INC|
Txns:
| Unknown transaction of 14,731,351 shares
@ $1.2, valued at
$17.7M
|
|
| 09/24/2019 |
SC 13D/A
| Raging Capital Management, LLC reports a 0% stake in Intermolecular, Inc. |
| 09/23/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/23/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/23/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/23/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/23/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/23/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/23/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/23/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/23/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/20/2019 |
4
| Furnas Matthew (Director) has filed a Form 4 on INTERMOLECULAR INC|
Txns:
| Unknown transaction of 75,000 options
@ $0.96, valued at
$72k
Unknown transaction of 25,000 options
@ $1.39, valued at
$34.8k
|
|
| 09/20/2019 |
4
| BURKETT MARVIN D (Director) has filed a Form 4 on INTERMOLECULAR INC|
Txns:
| Unknown transaction of 12,500 options
@ $6.2, valued at
$77.5k
Unknown transaction of 10,000 options
@ $6.62, valued at
$66.2k
Unknown transaction of 10,000 options
@ $8.21, valued at
$82.1k
Unknown transaction of 10,000 options
@ $2.59, valued at
$25.9k
Unknown transaction of 25,000 options
@ $1.82, valued at
$45.5k
Unknown transaction of 25,000 options
@ $1.85, valued at
$46.3k
Unknown transaction of 25,000 options
@ $0.85, valued at
$21.3k
Unknown transaction of 25,000 options
@ $1.39, valued at
$34.8k
|
|
| 09/20/2019 |
4
| TRAUB KENNETH H (Director) has filed a Form 4 on INTERMOLECULAR INC|
Txns:
| Unknown transaction of 75,000 options
@ $1.85, valued at
$138.8k
Unknown transaction of 25,000 options
@ $0.85, valued at
$21.3k
Unknown transaction of 25,000 options
@ $1.39, valued at
$34.8k
|
|
| 09/20/2019 |
4
| Schultz Jonathan B. (Director) has filed a Form 4 on INTERMOLECULAR INC|
Txns:
| Unknown transaction of 75,000 options
@ $1.39, valued at
$104.3k
|
|
| 09/20/2019 |
4
| FEDERMAN IRWIN (10% Owner) has filed a Form 4 on INTERMOLECULAR INC|
Txns:
| Unknown transaction of 538,267 shares
@ $0
Unknown transaction of 10,000 options
@ $6.62, valued at
$66.2k
Unknown transaction of 10,000 options
@ $8.21, valued at
$82.1k
Unknown transaction of 10,000 options
@ $2.59, valued at
$25.9k
Unknown transaction of 25,000 options
@ $1.82, valued at
$45.5k
Unknown transaction of 25,000 options
@ $1.85, valued at
$46.3k
Unknown transaction of 25,000 options
@ $0.85, valued at
$21.3k
Unknown transaction of 25,000 options
@ $1.39, valued at
$34.8k
|
|
| 09/20/2019 |
4
| SCALISE GEORGE (Director) has filed a Form 4 on INTERMOLECULAR INC|
Txns:
| Unknown transaction of 160,000 shares
@ $0
Unknown transaction of 10,000 options
@ $6.62, valued at
$66.2k
Unknown transaction of 10,000 options
@ $8.21, valued at
$82.1k
Unknown transaction of 10,000 options
@ $2.59, valued at
$25.9k
Unknown transaction of 25,000 options
@ $1.82, valued at
$45.5k
Unknown transaction of 25,000 options
@ $1.85, valued at
$46.3k
Unknown transaction of 25,000 options
@ $0.85, valued at
$21.3k
Unknown transaction of 25,000 options
@ $1.39, valued at
$34.8k
|
|
| 09/20/2019 |
4
| Kramer Christian (President and CEO) has filed a Form 4 on INTERMOLECULAR INC|
Txns:
| Unknown transaction of 850,000 shares
@ $0
Unknown transaction of 1,000,000 options
@ $1.35, valued at
$1.4M
Unknown transaction of 200,000 options
@ $0.83, valued at
$166k
Unknown transaction of 150,000 options
@ $1.3501, valued at
$202.5k
|
|
| 09/20/2019 |
4
| ROESCHLEIN BILL (CFO) has filed a Form 4 on INTERMOLECULAR INC|
Txns:
| Unknown transaction of 260,000 shares
@ $0
Unknown transaction of 100,000 options
@ $2.04, valued at
$204k
Unknown transaction of 54,000 options
@ $0.99, valued at
$53.5k
Unknown transaction of 250,000 options
@ $0.9, valued at
$225k
Unknown transaction of 60,000 options
@ $1.3501, valued at
$81k
|
|
| 09/20/2019 |
4
| Scheer Adam Louis Abraham (Director) has filed a Form 4 on INTERMOLECULAR INC|
Txns:
| Unknown transaction of 75,000 options
@ $1.39, valued at
$104.3k
|
|
| 09/20/2019 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 09/20/2019 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 08/14/2019 |
SC 13D/A
| Merck KGaA reports a 31% stake in INTERMOLECULAR, INC. |
| 08/08/2019 |
10-Q
| Quarterly Report for the period ended June 30, 2019 |
| 08/08/2019 |
8-K
| Quarterly results |
| 07/17/2019 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits |
| 06/28/2019 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 06/17/2019 |
GN
| Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Intermolecular, Electronics for Imaging, El Paso Electric, and Gardner Denver on Behalf of Stockholders and Encourages Investors to Contact the Firm |
| 06/12/2019 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 06/06/2019 |
GN
| ZAYO, CHSP, IMI Merger Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – ZAYO, CHSP, IMI |
| 05/28/2019 |
PREM14A
| Form PREM14A - Preliminary proxy statements relating to merger or acquisition: |
| 05/16/2019 |
SC 13D
| Merck KGaA reports a 31% stake in INTERMOLECULAR, INC. |
| 05/16/2019 |
SC 13D
| GAMCO INVESTORS, INC. ET AL reports a 3.6% stake in Intermolecular, Inc. |
|
|
|